Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
More patients receiving ruxolitinib have decrease of at least 75 percent from baseline in facial Vitiligo Area Scoring Index
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.